- Global Pharma News & Resources

Target U.S For Maximum Profitability in Biodefense Treatment Market, Says Fairfield Market Research


The demand for the biodefense treatment market is likely to witness an exponential rise in the next five years, predicts Fairfield Market Research.
Editor: Aarti Murkute Last Updated: 20-Jul-2021

Even though the UN has a convention against biological warfare, the threat of bioterrorism is greater than ever. To counter rogue pathogens and non-state actors, countries must beef up their R&D budgets of biodefense treatments. COVID-19 has raised numerous questions about global safety and security. Fairfield Market Research estimates that the biodefense treatment market should grow at an exponential rate for the forecast period ending in 2025.

For More Insights into the Market, Get Sample Copy of this Report::

Rising Geopolitical Tensions Compel Nations to Invest Larger Sums in Biodefense

The threat of bioterrorism and geopolitical tensions provide an incentive for countries to strengthen their conventional arsenal. Countries have boosted their defence budgets with a dedicated outlay for biological and chemical weapon warfare. Multiple geopolitical challenges and COVID-19 have completely changed the calculations of defence strategists. From the Middle East to the South China Sea, several long-standing territorial disputes show no signs of abating anytime soon. There has been a growing awareness about the implications of a bioterrorist attack leading to countries investing heavily in defensive capability. An emphasis on public health for developing robust diagnostic procedures that nip biothreats in the bud is driving the biodefense treatment market.

COVID-19 Variants Ensure the Pre-eminence of Segment in Biodefense Treatment Market

In 2019, the vaccine segment recorded the highest revenue in the biodefense treatment market and COVID-19 should accentuate this trend. Governments are working round the clock to eliminate the scourge of COVID-19, especially as new variants potentially undo all the progress made so far. The U.S. government has a Strategic National Stockpile (SNS) in place to tackle any bioterror attacks. The detection devices segment is anticipated to witness a moderate rate of growth for the five year period analysed. Rapid detection systems are gaining popularity in the biodefense treatment market as they are a critical component of the federal effort to strengthen American biodefense post 9/11.

In Order to place the Purchase Query Click Here:

 Biodefense Strategies Enable U.S to Retain Leadership in Biodefense Treatment Market

The U.S has the largest defence budget in the world and spends more than the next five countries combined. It has a number of biodefense strategies including BARDA, HHS, ASPR, and NIAID, allowing it to retain pole position in the biodefense treatment market. Europe will demonstrate the highest growth as countries there have realised the pitfalls of an overreliance on outsourcing, scaling up their local R&D and manufacturing. APAC is not far behind either with Australia and Japan having the most stringent safety and quality norms that other countries strive to emulate.

Browse Our Latest Reports:

About Us

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.